Literature DB >> 1988447

Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase.

M Spaargaren1, L H Defize, J Boonstra, S W de Laat.   

Abstract

The relationship between epidermal growth factor receptor (EGF-R) protein tyrosine kinase activation and ligand-induced receptor dimerization was investigated using several bivalent anti-EGF-R antibodies directed against various receptor epitopes. In A431 membrane preparations and permeabilized cells, all antibodies were able to activate the EGF-R tyrosine kinase, as measured by EGF-R autophosphorylation and phosphorylation of other substrates on tyrosine residues. EGF-R tyrosine kinase activation correlated strongly with the induction of EGF-R dimerization. (i) Both processes specifically occurred in a narrow antibody concentration range; (ii) both processes required the presence of detergent; and (iii) both processes depended on antibody bivalence since monovalent Fab fragments were inactive yet regained full activity after cross-linking by a second bivalent antibody. These data demonstrate that antibody bivalence is essential and sufficient for EGF-R activation and that activation occurs regardless of the EGF-R epitope recognized. Finally, EGF-R dimerization was shown not to depend on receptor autophosphorylation since it still occurred in the absence of ATP. Also, partial inhibition of the tyrosine kinase activity by the specific EGF-R tyrosine kinase inhibitor tyrphostin AG 213 did not affect formation of EGF-R dimers. Taken together these results demonstrate that induction of EGF-R dimerization is sufficient and in case of antibody action, essential, for activation of the EGF-R tyrosine kinase and thus provide strong support for an intermolecular mechanism of EGF-R tyrosine kinase activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988447

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency.

Authors:  U Srinivas; E Tagliabue; M Campiglio; S Ménard; M I Colnaghi
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

2.  Excess reactive oxygen species production mediates monoclonal antibody-induced human embryonic stem cell death via oncosis.

Authors:  Ji Yun Zheng; Heng Liang Tan; Paul Thomas Matsudaira; Andre Choo
Journal:  Cell Death Differ       Date:  2017-01-20       Impact factor: 15.828

3.  Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype.

Authors:  N Ortéga; F Jonca; S Vincent; C Favard; M M Ruchoux; J Plouët
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 4.  Signal transduction by Ras-like GTPases: a potential target for anticancer drugs.

Authors:  M Spaargaren; J R Bischoff; F McCormick
Journal:  Gene Expr       Date:  1995

5.  Antibody quantum dot conjugates developed via copper-free click chemistry for rapid analysis of biological samples using a microfluidic microsphere array system.

Authors:  Nalinikanth Kotagiri; Zhenyu Li; Xiaoxiao Xu; Suman Mondal; Arye Nehorai; Samuel Achilefu
Journal:  Bioconjug Chem       Date:  2014-06-17       Impact factor: 4.774

6.  Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration.

Authors:  C G Schalkwijk; M A van der Heijden; G Bunt; R Maas; L G Tertoolen; P M van Bergen en Henegouwen; A J Verkleij; H van den Bosch; J Boonstra
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

7.  Implications of epidermal growth factor (EGF) induced egf receptor aggregation.

Authors:  C Wofsy; B Goldstein; K Lund; H S Wiley
Journal:  Biophys J       Date:  1992-07       Impact factor: 4.033

8.  TrkA cross-linking mimics neuronal responses to nerve growth factor.

Authors:  D O Clary; G Weskamp; L R Austin; L F Reichardt
Journal:  Mol Biol Cell       Date:  1994-05       Impact factor: 4.138

9.  Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation.

Authors:  T W Gadella; T M Jovin
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

10.  Characterization and identification of an epidermal-growth-factor-activated phospholipase A2.

Authors:  M Spaargaren; S Wissink; L H Defize; S W de Laat; J Boonstra
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.